Department of Pediatric Nephrology, St. John's Medical College Hospital, Bengaluru, India.
INHS Asvini, Mumbai, India.
Indian Pediatr. 2021 Jul 15;58(7):650-666. Epub 2021 Jan 4.
The management of steroid resistant nephrotic syndrome (SRNS) is challenging. These guidelines update existing 2009 Indian Society of Pediatric Nephrology recommendations on its management.
To frame revised guidelines on diagnosis and evaluation, treatment and follow up, and supportive care of patients with the illness.
The guidelines combine evidence-based recommendations and expert opinion. Formulation of key questions was followed by systematic review of literature, evaluation of evidence by experts and two face-to-face meetings.
Fourteen statements provide updated advice for managing steroid resistance, and underscore the importance of estimating proteinuria and baseline kidney function, and the need for kidney biopsy and genetic screening. Calcineurin inhibitors are recommended as most effective in inducing remission of proteinuria, the chief factor associated with long-term renal survival. Advice on managing allograft recurrence, congenital nephrotic syndrome, and monitoring and supportive care, including transition of care, are described. This revised practice guideline is intended to improve management and patient outcomes, and provide direction for future research.
类固醇耐药性肾病综合征(SRNS)的治疗具有挑战性。本指南更新了印度儿科学会肾脏病学分会 2009 年关于其治疗的现有建议。
制定关于疾病诊断和评估、治疗和随访以及支持性治疗的修订指南。
该指南结合了循证建议和专家意见。首先制定关键问题,然后对文献进行系统回顾,由专家评估证据,并进行两次面对面会议。
十四条陈述提供了管理类固醇耐药性的最新建议,强调了估计蛋白尿和基线肾功能的重要性,以及进行肾活检和基因筛查的必要性。钙调神经磷酸酶抑制剂被推荐为最有效地诱导蛋白尿缓解,这是与长期肾脏生存相关的主要因素。还描述了管理移植物复发、先天性肾病综合征以及监测和支持性治疗(包括治疗过渡)的建议。本修订后的实践指南旨在改善管理和患者预后,并为未来的研究提供方向。